Emcure Pharmaceuticals Ltd., a leading Indian pharma company with a strong focus on women’s health, announces its entry into the daily supplements space with the expansion of its Arth range. With a ...

Motilal Oswal, has come out with its report on Emcure Pharmaceuticalss Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.

Emcure Pharmaceuticals, an Indian pharma company focused on women’s health, has entered the daily supplements market with an expansion of its Arth range. Arth offers supplements that combine ...

Emcure Pharmaceuticals has opened its new formulation research and development (R&D) centre in Ahmedabad, in the Indian state of Gujarat. The centre will focus on developing complex drug delivery ...

New Delhi: Emcure Pharmaceuticals has announced its entry into the daily supplements space by expanding its Arth range. Arth manufactures supplements that use Indian herbs like Brahmi and modern ...

Pune-based Emcure Pharmaceuticals has come forth again to publicly list its shares on exchanges. In 2014, the company had attempted to hit the stock exchanges, but reportedly did not pursue it ...

Emcure Pharmaceuticals Ltd has announced its entry into the daily supplements space with the expansion of its Arth range, and partnered with actor Vidya Balan as the brand ambassador for the range ...